Platelet membrane-based and tumor-associated platelettargeted drug delivery systems for cancer therapy.
10.1007/s11684-017-0583-y
- Author:
Yinlong ZHANG
1
;
Guangna LIU
1
;
Jingyan WEI
2
;
Guangjun NIE
3
Author Information
1. College of Pharmaceutical Science, Jilin University, Changchun, 130021, China.
2. College of Pharmaceutical Science, Jilin University, Changchun, 130021, China. jingyanweijluedu@163.com.
3. CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, 100190, China. niegj@nanoctr.cn.
- Publication Type:Journal Article
- Keywords:
EPR effect;
cancer therapy;
platelet-mimicking delivery systems;
tumor-associated platelets
- MeSH:
Animals;
Antineoplastic Agents;
chemistry;
pharmacology;
Biomimetic Materials;
chemistry;
Blood Platelets;
cytology;
Drug Carriers;
chemistry;
Humans;
Models, Animal;
Nanomedicine;
methods;
Nanostructures;
chemistry;
Neoplasms;
drug therapy
- From:
Frontiers of Medicine
2018;12(6):667-677
- CountryChina
- Language:English
-
Abstract:
Platelets have long been known to play critical roles in hemostasis by clumping and clotting blood vessel injuries. Recent experimental evidence strongly indicates that platelets can also interact with tumor cells by direct binding or secreting cytokines. For example, platelets have been shown to protect circulating cancer cells in blood circulation and to promote tumor metastasis. In-depth understanding of the role of platelets in cancer progression and metastasis provides promising approaches for platelet biomimetic drug delivery systems and functional platelet-targeting strategies for effective cancer treatment. This review highlights recent progresses in platelet membrane-based drug delivery and unique strategies that target tumor-associated platelets for cancer therapy. The paper also discusses future development opportunities and challenges encountered for clinical translation.
